Ingenio Care
Category: AI in Healthcare
AI-enabled patient-centric digital health network designed to improve care coordination and outcomes for chronic disease management. Ingenio Care was founded in 2024. The company is led by Alex Kumar. Based in Oak Brook, Illinois, USA. Team size: <10. Total funding raised: Undisclosed. Latest round: Pre-seed. Key investors include Nina Capital, Unnamed strategic angel investors.
- Founded
- 2024
- Headquarters
- Oak Brook, Illinois, USA
- Team size
- <10
- Total funding
- Undisclosed
Value proposition
Empowers care teams with AI-driven insights to deliver personalized interventions at scale, improving patient engagement, reducing costs, and enhancing clinical outcomes. Aims to cut patient wait times by 30-50% by intelligently matching them with underutilized providers.
Products and solutions
AI-powered risk stratification & predictive analytics, Personalized care pathway recommendations, Integrated communication tools for multidisciplinary teams, Patient engagement modules via mobile/web apps, Data integration from EHRs, wearables, and social determinants sources
Unique value
A holistic approach that integrates clinical data with social determinants of health, using advanced AI models tailored for high-risk and chronic populations in resource-constrained settings.
Target customer
Healthcare providers (clinics/hospitals), payers, Independent Practice Associations (IPAs), employers, and care teams managing patients with chronic conditions, particularly in underserved populations.
Industries served
Healthcare delivery organizations (hospitals/clinics), Population health managers/payers, Employers, Independent Practice Associations (IPAs)
Technology advantage
Proprietary algorithms combining medical, behavioral, and social data for more accurate risk prediction; seamless integration into clinical workflows; an 'equity-first' design to address care gaps.
How they differentiate
Positions itself at the intersection of advanced AI-driven personalization and deep integration into both clinical and social domains, with a strong emphasis on an 'equity-first' approach for scalable deployment. Aims to reduce patient wait times significantly by optimizing provider utilization.
Main competitors
Cityblock Health, CareBridge, Healthify (now part of WellSky)
Key partnerships
Seeking initial pilot partners, including IPAs, employers, and health plans.
Notable customers
No publicly named customers yet. Currently recruiting for initial pilot programs with IPAs, employers, and health plans.
Major milestones
Secured pre-seed funding in June 2024 Platform MVP developed First pilot deployments scheduled
Growth metrics
N/A (early-stage, pre-launch).
Market positioning
A specialized platform for chronic disease management that combines AI-personalization with a focus on health equity and social determinants of health.
Geographic focus
Primarily U.S.-based market entry, with a platform designed to be extensible globally.
Patents and IP
No public patents listed yet.
About Alex Kumar
Alex Kumar is a seasoned entrepreneur and innovator in the digital health sector. He is the Founder and CEO of Ingenio Care, Inc., a company focused on improving chronic disease management through an AI-enabled, patient-centric digital health network. He is also the CEO of Ingenio Healthcare. His entrepreneurial journey includes co-founding R1RCM and Mphasis Corp, showcasing his extensive experience in building and leading successful healthcare and technology companies. His expertise lies in healthcare models, business strategy, and data-driven solutions.
Official website: https://ingeniocare.com/